Literature DB >> 22134354

miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions.

Helge Siemens1, Rene Jackstadt, Sabine Hünten, Markus Kaller, Antje Menssen, Ursula Götz, Heiko Hermeking.   

Abstract

Recently, the inhibition of epithelial-mesenchymal-transition (EMT) by p53 has been described as a new mode of tumor suppression which presumably prevents metastasis. Here we report that activation of p53 down-regulates the EMT-inducing transcription factor SNAIL via induction of the miR-34a/b/c genes. Suppression of miR-34a/b/c caused up-regulation of SNAIL and cells displayed EMT markers and related features, as enhanced migration and invasion.  Ectopic miR-34a induced mesenchymal-epithelial-transition (MET) and down-regulation of SNAIL, which was mediated by a conserved miR-34a/b/c seed-matching sequence in the SNAIL 3'-UTR. miR-34a also down-regulated SLUG and ZEB1, as well as the stemness factors BMI1, CD44, CD133, OLFM4 and c-MYC. Conversely, the transcription factors SNAIL and ZEB1 bound to E-boxes in the miR-34a/b/c promoters, thereby repressing miR-34a and miR-34b/c expression. Since ectopic miR-34a prevented TGF-β-induced EMT, the repression of miR-34 genes by SNAIL and related factors is part of the EMT program. In conclusion, the frequent inactivation of p53 and/or miR-34a/b/c found in cancer may shift the equilibrium of these reciprocal regulations towards the mesenchymal state and thereby lock cells in a metastatic state.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22134354     DOI: 10.4161/cc.10.24.18552

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  249 in total

1.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

Review 2.  MiR-34 and MiR-200: Regulator of Cell Fate Plasticity and Neural Development.

Authors:  Abhishek Jauhari; Sanjay Yadav
Journal:  Neuromolecular Med       Date:  2019-04-08       Impact factor: 3.843

Review 3.  To differentiate or not--routes towards metastasis.

Authors:  Thomas Brabletz
Journal:  Nat Rev Cancer       Date:  2012-05-11       Impact factor: 60.716

Review 4.  The emerging functions of the p53-miRNA network in stem cell biology.

Authors:  Chao-Po Lin; Yong Jin Choi; Geoffrey G Hicks; Lin He
Journal:  Cell Cycle       Date:  2012-06-01       Impact factor: 4.534

5.  MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination.

Authors:  Mingyang Lu; Mohit Kumar Jolly; Herbert Levine; José N Onuchic; Eshel Ben-Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-23       Impact factor: 11.205

Review 6.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

7.  MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).

Authors:  Jiali Zhang; Yu Wang; Xinming Chen; Yi Zhou; Fangyan Jiang; Jirong Chen; Li Wang; Wen-Feng Zhang
Journal:  Oncotarget       Date:  2015-04-10

Review 8.  Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.

Authors:  E-Jean Tan; Anna-Karin Olsson; Aristidis Moustakas
Journal:  Cell Adh Migr       Date:  2014-11-17       Impact factor: 3.405

9.  microRNA-34a promotes DNA damage and mitotic catastrophe.

Authors:  Alexander V Kofman; Jungeun Kim; So Yeon Park; Evan Dupart; Christopher Letson; Yongde Bao; Kai Ding; Quan Chen; David Schiff; James Larner; Roger Abounader
Journal:  Cell Cycle       Date:  2013-09-19       Impact factor: 4.534

10.  Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition.

Authors:  Juanjuan Ou; Hongming Miao; Yinyan Ma; Feng Guo; Jia Deng; Xing Wei; Jie Zhou; Ganfeng Xie; Hang Shi; Bingzhong Xue; Houjie Liang; Liqing Yu
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.